COVID-19: Is Monoclonal Antibody Therapy Really Feasible?
In light of US President Donald Trump's COVID-19 treatment, the success of monoclonal antibody therapy for the treatment of the disease is being widely discussed.
In light of US President Donald Trump's COVID-19 treatment, the success of monoclonal antibody therapy for the treatment of the disease is being widely discussed. However, is this really a feasible option? In this interview with NewsClick, Dr. Satyajit Rath talks about the limitations of this line of treatment and the future of vaccine development for COVID-19.
Get the latest reports & analysis with people's perspective on Protests, movements & deep analytical videos, discussions of the current affairs in your Telegram app. Subscribe to NewsClick's Telegram channel & get Real-Time updates on stories, as they get published on our website.
